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MaOBJECTIVES The present study aimed to investigate the difference in major adverse cardiac events (MACE) at 3 years
after double-kissing (DK) crush versus culotte stenting for unprotected left main distal bifurcation lesions (LMDBLs).
BACKGROUND The multicenter and randomized DKCRUSH-III (Comparison of double kissing crush versus culotte
stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective study)
showed that DK crush stenting was associated with fewer MACE at 1-year follow-up in patients with LMDBLs compared
with culotte stenting. Here, we report the 3-year clinical outcome of the DKCRUSH-III study.
METHODS A total of 419 patients with LMDBLs who were randomly assigned to either the DK crush or culotte group in
the DKCRUSH-III study were followed for 3 year. The primary endpoint was the occurrence of a MACE at 3 years. Stent
thrombosis (ST) was the safety endpoint. Patients were classiﬁed by simple and complex LMDBLs according to the
DEFINITION (Deﬁnition and Impact of Complex Bifurcation Lesions on Clinical Outcomes After Percutaneous Coronary
Intervention Using Drug-Eluting Stents) study criteria.
RESULTS At 3 years, MACE occurred in 49 patients the culotte group and in 17 patients in the DK crush group
(cumulative event rates of 23.7% and 8.2%, respectively; p < 0.001), mainly driven by increased myocardial infarction
(8.2% vs. 3.4%, respectively; p ¼ 0.037) and target-vessel revascularization (18.8% vs. 5.8%, respectively; p < 0.001)
between groups. Deﬁnite ST rate was 3.4% in the culotte group and 0% in the DK crush group (p ¼ 0.007). Complex
LMDBLs were associated with a higher rate of MACE (35.3%) at 3 years compared with a rate of 8.1% in patients with
simple LMDBLs (p < 0.001), with an extremely higher rate in the culotte group (51.5% vs. 15.1%, p < 0.001).
CONCLUSIONS Culotte stenting for LMDBLs was associated with signiﬁcantly increased rates of MACE and ST.
(Double Kissing [DK] Crush Versus Culotte Stenting for the Treatment of Unprotected Distal Left Main Bifurcation
Lesions: DKCRUSH-III, a Multicenter Randomized Study Comparing Double-Stent Techniques; ChiCTR-TRC-11001877)
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ABBR EV I A T I ON S
AND ACRONYMS
CABG = coronary artery bypass
grafting
DK = double-kissing
IVUS = intravascular
ultrasound
LMDBL = left main distal
bifurcation lesion
MACE = major adverse
cardiac event(s)
MI = myocardial infarction
SB = side branch
ST = stent thrombosis
TLR = target lesion
revascularization
TVR = target vessel
revascularization
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1336A body of evidence has demonstratedthat coronary artery bypass grafting(CABG) remains the standard treat-
ment for patients with unprotected left
main coronary artery disease (1–3), mainly
driven by an increased rate of target lesion
revascularization (TLR). Given the relatively
simple stenting technique and comparable
clinical results after percutaneous coronary
intervention using drug-eluting stent place-
ment for lesions that are ostial or body/shaft
of the unprotected left main coronary artery
(4,5), stenting left main distal bifurcation le-
sions (LMDBLs) remains a matter of debate.
Furthermore, although provisional stenting
is recommended for the great majority of cor-
onary bifurcation lesions, a recent report
showed a higher rate of cardiac death afterthe single-stent technique for LMDBLs (6). On the
other hand, LMDBLs often require 2-stent techniques,
which results in less favorable long-term out-
comes (7–9). Unfortunately, there is no consensus
on the best option for elective stenting with system-
atic double-stent techniques. In the randomized
DKCRUSH-III (Comparison of double kissing crush
versus culotte stenting for unprotected distal left
main bifurcation lesions: results from a multicenter,
randomized, prospective study) study (10), we
compared the DK crush and culotte stenting tech-
niques for LMDBLs and observed fewer major adverse
cardiac event (MACE) and TLR at 1-year follow-up in
the DK crush group. There are no data showing theSEE PAGE 1343
FIGURE 1 Study Flowchart
Four patients were lost to 3-year follow-up, with 2 patients in
each group. Finally, 415 patients (208 in the DK and 207 in the
Culotte group, respectively) formed the basis of the current
study. DK ¼ double kissing.long-term clinical outcomes of 2-stent techniques for
LMDBLs, particularly with regard to TLR and safety
endpoint—stent thrombosis (ST). Accordingly, the
aim of the current study was to evaluate the 3-year
clinical outcome after DK crush and culotte stenting
for the patient population from DKCRUSH-III study.
The outcome in those patients was also compared
in a subgroup stratiﬁed by DEFINITION (Deﬁnition
and Impact of Complex Bifurcation Lesions on Clin-
ical Outcomes After Percutaneous Coronary Interven-
tion Using Drug-Eluting Stents) study criteria (11), a
stratiﬁcation system used to differentiate simple
from complex LMDBLs.
METHODS
STUDY DESIGN AND PATIENT POPULATION. The
DKCRUSH-III study was an international (5 coun-
tries), multicenter (n ¼ 18), randomized study that
was designed to compare the DK crush and theculotte stenting techniques for patients with
LMDBLs. The primary endpoint of the primary pub-
lication (10) was the 12-month composite of MACE
including cardiac death, myocardial infarction (MI),
and target vessel revascularization (TVR), whereas
angiographic follow-up was performed 8 months after
the indexed procedures. The study protocol was
approved by the Ethics Committee of the 19 partici-
pating centers, and written consent was obtained
from all patients or their legally authorized repre-
sentative. The recruitment of participating centers
was strictly according to our protocol (12). The clinical
follow-up was scheduled to be performed as 3 years,
as shown in Figure 1. Finally, between March 24, 2009
and October 22, 2011, a total of 419 patients were
enrolled (210 in the DK crush and 209 in the culotte
group). In brief, patients were eligible if they had
ischemic symptoms or evidence of myocardial
ischemia in the presence of a Medina (13) 1,1,1 or 0,1,1
de novo LMDBLs. For inclusion, the maximal treat-
able lesion length by visual estimation for each indi-
vidual branch had to be completely covered by 2
drug-eluting stents. The exclusion criteria have
been described in detail previously (10). Patients were
randomly assigned to the study groups in a 1:1 ratio
before undergoing balloon dilation. The recom-
mended stents were Firebird-2 (balloon-expandable,
cobalt chromium–based, sirolimus-eluting stent,
Microport Co., Shanghai, China) and Xience V (Abbott
Vascular, Irvine, California). The main stenting tech-
niques were described previously (10). Final KB was
recommended at the end of procedure for all lesions.
MEDICATIONS. A 300-mg loading dose of clopidogrel
was administered before the index procedure if the
patient was not pretreated. After the intervention, all
TABLE 2 Clinical Outcomes After DK Crush and Culotte Stenting
DK Crush
(n ¼ 208)
Culotte
(n ¼ 207) p Value
1-year MACE* 13 (6.2) 34 (16.1) 0.001
Cardiac death 2 (1.0) 2 (1.0) 1.000
MI 7 (3.3) 11 (5.3) 0.377
TLR 5 (2.4) 14 (6.7) 0.037
CABG 2 (1.0) 0 0.499
TVR 9 (4.3) 22 (10.5) 0.016
ST 1 (0.5) 2 (1.0) 0.623
Deﬁnite 0 2 (1.0) 0.248
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1337patients received 300 mg/day aspirin for 1 month;
thereafter, they received 100 mg/day for life. Clopi-
dogrel (75 mg/day) was continued for at least 12
months. After 1 year, clopidogrel was not routinely
prescribed and left to the discretion of the patients’
physician.
DEFINITION OF STUDY ENDPOINTS. The primary
endpoint was the occurrence of a MACE at 3 years,
which includedMI, cardiac death, and/or TVR. The rate
of deﬁnite and probable ST served as a safety endpoint.
MI was diagnosed if the plasma level of creatine
kinase-myocardial band and/or troponin I/T increased
tomore than 3 times the upper normal limit in no fewer
than 2 blood samples. All deaths were considered car-
diac in origin unless noncardiac reasons were indi-
cated. TLR and TVR were deﬁned as any repeat
revascularization (percutaneous coronary interven-
tion or CABG) for target lesions and target vessels,
respectively, in the presence of symptoms or objective
signs of ischemia. ST was deﬁned according to the
Academic Research Consortium deﬁnition (14).
STATISTICAL ANALYSIS. The calculation of patient
sample size was described previously (10). The
treatment group differences were evaluated with the
t test or Wilcoxon rank sum scores for continuous
variables as appropriate. The chi-square test or
the Fisher exact test was used to analyze categorical
variables. Survival rates free from events were
generated by Kaplan-Meier analysis, and they wereTABLE 1 Clinical, Angiographic and Procedural Characteristics
DK Group
(n ¼ 210)
Culotte Group
(n ¼ 209) p Value
Clinical
Male 162 (77.1) 167 (79.9) 0.552
Age, yrs 64.3  10.3 63.3  9.2 0.296
Hypertension 148 (70.5) 128 (61.2) 0.055
Hyperlipidemia 87 (41.4) 88 (42.1) 0.921
Diabetes 67 (31.9) 63 (30.1) 0.298
Angiographic
3-vessel disease 149 (71.3) 145 (69.5) 0.130
Patterns of bifurcation 0.896
Medina 1,1,1 207 (98.7) 198 (94.8)
Medina 0,1,1 3 (1.3) 11 (5.2)
IVUS assessment 145 (69.0) 154 (73.7) 0.331
Procedural
Post-dilation
Main vessel 205 (97.6) 200 (95.7) 0.293
Side branch 202 (96.2) 200 (95.7) 0.810
Final kissing balloon inﬂation 209 (99.5) 208 (99.5) 1.000
Angiographic success 204 (97.1) 208 (99.5) 0.122
Complete revascularization 180 (85.7) 171 (82.0) 0.351
Values are n (%) or mean  SD.
DK ¼ double-kissing; IVUS ¼ intravascular ultrasound.compared using the log-rank test. Patients were
classiﬁed by simple and complex subgroups according
to DEFINITION study criteria (11). Brieﬂy, a complex
LMDBL was deﬁned as a side branch (SB) diameter
stenosis minimum of 90% and SB lesion length
$10 mm, plus at least 2 minor criteria (including
left main-left anterior descending artery lesions
$25 mm, moderate or severe calciﬁcation, bifurcation
angle #45, multiple lesions, and thrombus-
containing lesions). We also included center as a
random effect in our analysis. Statistical signiﬁcance
was taken as a 2-sided p value <0.05. All analyses
were performed with the statistical program SPSS
version 16.0 (SPSS Institute Inc., Chicago, Illinois).
RESULTS
Baseline clinical and procedural characteristics
(Table 1) were well matched in the 2 groups (10).Probable 0 0 NS
Possible 1 (0.5) 0 1.000
2-year MACE 15 (7.2) 47 (22.7) <0.001
Cardiac death 3 (1.4) 6 (2.9) 0.338
MI 7 (3.4) 16 (7.7) 0.046
TLR 7 (3.4) 27 (13.0) <0.001
CABG 2 (1.0) 1 (0.5) 0.623
TVR 10 (4.8) 37 (17.1) <0.001
ST 1 (0.5) 8 (3.9) 0.020
Deﬁnite 0 7 (3.4) 0.007
Probable 0 1 (0.5) 0.499
Possible 1 (0.5) 0 0.318
3-year MACE 17 (8.2) 49 (23.7) <0.001
Cardiac death 3 (1.4) 6 (2.9) 0.338
MI 7 (3.4) 17 (8.2) 0.037
TLR 8 (3.8) 29 (14.0) <0.001
CABG 2 (1.0) 1 (0.5) 0.565
TVR 12 (5.8) 39 (18.8) <0.001
ST 1 (0.5) 8 (3.9) 0.020
Deﬁnite 0 7 (3.4) 0.007
Probable 0 1 (0.5) 0.499
Possible 1 (0.5) 0 0.318
Values are n (%). *Indicates that patient number was 210 in the DK and 209 in the Culotte groups,
respectively.
DK ¼ double-kissing; CABG ¼ coronary artery bypass grafting; MACE ¼ major adverse cardiac
event; MI ¼ myocardial infarction; ST ¼ stent thrombosis; TLR ¼ target lesion revascularization;
TVR ¼ target vessel revascularization.
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1338There were 246 patients from centers in China and
173 patients from centers outside China, 7.2% of
patients had recent MI (>2 weeks). Three-vessel dis-
eases were seen in 70% of patients. The localization
of lesions within the left man coronary artery was
virtually the same. More than 96% of distal bifur-
cation lesions were stratiﬁed by Medina 1,1,1.
Pre-procedural intravascular ultrasound (IVUS)
assessment was used in >70% of patients. Post-
dilation was performed in >95% of patients. Final
kissing balloon inﬂation was not performed in 1 case
in each group, respectively. Angiographic success was
achieved in >98% of patients. Complete revasculari-
zation was achieved in 85.7% in the DK crush groupFIGURE 2 Kaplan-Meier 3-Year Survival Analysis in DK and Culotte
Cumulative survival rate free from MACE (A), ST (B), TLR (C), and MI (D)
treated by DK crush and culotte stenting techniques. DK ¼ double kissi
MI ¼ myocardial infarction; ST ¼ stent thrombosis; TLR ¼ target lesionand 82.0% in the culotte group, respectively. Post-
stent assessment using IVUS was performed in
>85% of patients.
Four patients were lost to 3-year follow-up
(Figure 1), 2 patients in each group. Finally, 415 pa-
tients (208 in the DK crush group and 207 in the culotte
group, respectively) formed the basis of the current
study. Aspirin was not taken by 2 patients in the DK
crush group and by 1 patient in the culotte group. Dual-
antiplatelet therapy was prescribed in 96 patients
(46.2%) in the DK crush group, nonsigniﬁcant at
93 patients (44.9%) in the culotte group (p > 0.05).
Repeat angiography was performed in 176 patients
in the DK crush group and 174 in the culotte group atGroups
at 3-year follow-up in patients with left main distal bifurcation lesions
ng; Cum ¼ cumulative; MACE ¼ major adverse cardiac events;
revascularization.
TABLE 3 The 3-Year Clinical Outcomes After Stenting in Patients
With Complex and Simple Left Main Distal Bifurcation Lesions
Complex
(n ¼ 119)
Simple
(n ¼ 296) p Value
MACE 42 (35.3) 24 (8.1) <0.001
Cardiac death 6 (5.0) 3 (1.0) 0.019
MI 16 (13.4) 8 (2.7) <0.001
TLR 28 (23.5) 9 (3.0) <0.001
CABG 3 (2.5) 0 0.023
TVR 33 (27.7) 18 (6.1) <0.001
ST 6 (5.0) 3 (1.0) 0.019
Deﬁnite 4 (3.4) 3 (1.0) 0.108
Probable 1 (0.8) 0 0.287
Deﬁnite/probable 5 (4.2) 3 (1.0) 0.047
Possible 1 (0.8) 0 0.287
Values are n (%).
Abbreviations as in Table 2.
FIGURE 3 Landmark Analysis for Percentage of Survival of
2 Groups
DK ¼ double kissing.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 0 , 2 0 1 5 Chen et al.
A U G U S T 2 4 , 2 0 1 5 : 1 3 3 5 – 4 2 3-Year Follow-Up of the DKCRUSH-III Study
13398 months after the index stenting procedure, and it
was performed in additional 28 patients in the DK
crush group and 31 in the culotte group at 2-year
follow-up. At 3-year follow-up, angiography was
performed in another 7 patients in the DK crush group
and in 13 in the culotte group.
Clinical results are shown in Table 2. Based on
angiography at 8 months after the index procedure,
revascularization was performed in 3 patients (1 in
the DK crush group and 2 in the culotte group) who
had visual diameter stenosis $90% without chest
pain, but a treadmill test was positive for these
3 patients. At 1-year follow-up, there were more
frequent MACE (16.4%) and TVR (11.1%) in the
culotte group compared with the DK crush group
(6.3%, p ¼ 0.001 and 4.3%, p ¼ 0.010). At 2- and 3-
year follow-up, the cumulative incidences of MACE
were 22.7% and 23.7%, respectively, in the culotte
group and 7.2% and 8.2% in the DK crush group,
respectively (all p < 0.001) (Table 1), mainly driven
by increased rates of MI (7.7% vs. 3.4%, p ¼ 0.046,
and 8.2% vs. 3.4%, p ¼ 0.037) and TVR (17.1% vs.
4.8%, p < 0.001, and 18.8% vs. 5.8%, p < 0.001) in
the culotte group. Of patients who had MI, revas-
cularization was performed in 3 in the DK crush
group and in 5 in the culotte group, respectively.
The rates of MACE-free survival are shown in
Figure 2A. There was no signiﬁcant difference in
MACE or individual endpoint among centers or
among countries.
By 3 years after the index procedures, the rate of
deﬁnite and probable ST was 3.9% in the culotte
group and 0% in the DK crush group (p ¼ 0.004)
(Table 2). The rates of event-free survival of deﬁnite
and probable ST are shown in Figure 2B. In the culotte
group, the rates of early (<30 days), late (within
1 year), and very late (>1 year) ST was 0.5%, 1.0%, and
2.4%, respectively. All patients having a deﬁnite or
probable ST were taking DAPT. The rates of event-
free survival of TLR and MI are shown in Figures 2C
and 2D. Landmark analysis of the percentage of sur-
vival is shown in Figure 3.
According to the DEFINITION study criteria, 119
patients (28.7%) were classiﬁed by complex LMDBLs
and 296 (71.3%) patients were included in the simple
LMDBL subgroup. There were signiﬁcant differences
in the 3-year rates of MACE and deﬁnite and probable
ST between simple (8.1% and 1.0%, respectively) and
complex (35.3% and 5.0%, respectively) (p < 0.001
and p ¼ 0.047, respectively) (Table 3, Figure 4),
particularly in patients with complex LMDBLs treated
by culotte stenting (51.5% and 7.6%, respectively)
(Table 4) compared with DK crush stenting for com-
plex LMDBLs (15.1% and 1.9%). DK crush stenting forcomplex LMDBLs still tended to be associated with
acceptable rates of MACE and ST at 3-year follow-up
compared with simple LMDBLs after DK crush
treatment.
DISCUSSION
To our knowledge, the DKCRUSH-III study is the only
multicenter and randomized study comparing DK
crush with culotte stenting techniques for patients
with LMDBLs. Our results showed that the difference
in MACE between the 2 studied groups was sustained
and became greater through 3-year follow-up.
Another important ﬁnding was the increased 3-year
rate of deﬁnite and probable ST in the culotte
group, which translated into more frequent cardiac
death and MI.
TABLE 4 The 3-Year
Bifurcation Lesions A
MACE
Cardiac death
MI
TLR
CABG
TVR
ST
Deﬁnite
Probable
Deﬁnite/probable
Possible
Values are n (%). *Compar
Abbreviations as in Tabl
FIGURE 4 Kaplan-Meier 3-Year Survival Analysis in
Complex and Simple Subgroups
Cumulative survival rate free from MACE at 3-year follow-up in
patients with complex and simple left main distal bifurcation
lesion after stenting. Abbreviations as in Figure 2.
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1340The 1-year clinical outcome after culotte stenting
for coronary bifurcation lesions has been reported in 3
studies (10,12,15). In ISAR-LEFT MAIN (Paclitaxel-
versus sirolimus-eluting stents for unprotected left
main coronary artery disease) study (15), 384 patients
with distal unprotected left main coronary artery le-
sions were treated by 2-stent techniques (98%
received culotte stenting), the 1-year TLR and MACE
rates in the Cypher group were 7.8% and 15.8%,
respectively, and compared well with the culotte
group from the DKCRUSH-III study (6.7% and 14.4%,Clinical Outcomes in Simple and Complex Left Main Distal
fter Either DK Crush or Culotte Stenting
DK Crush (n ¼ 208) Culotte (n ¼ 207)
p Value*
Simple
(n ¼ 155)
Complex
(n ¼ 43)
Simple
(n ¼ 141)
Complex
(n ¼ 66)
9 (5.8) 8 (15.1) 15 (10.6) 34 (51.5) <0.001
1 (0.6) 2 (3.8) 2 (1.4) 4 (6.1) 0.691
3 (1.9) 4 (7.5) 5 (3.5) 12 (18.2) 0.110
4 (2.6) 4 (7.5) 5 (3.5) 24 (36.4) <0.001
0 2 (3.8) 0 1 (1.5) 0.585
6 (3.9) 6 (11.3) 12 (8.5) 27 (40.9) <0.001
0 1 (1.9) 3 (2.1) 5 (7.6) 0.224
0 0 3 (2.1) 4 (6.1) 0.128
0 0 0 1 (1.5) 0.368
0 0 3 (2.1) 5 (7.6) 0.041
0 1 (1.9) 0 0 0.445
ison of complex DK and complex culotte.
e 2.respectively) and the Nordic Stent Study (12). How-
ever, long-term clinical results after culotte stenting
was only reported in the present study and the
Nordic Stent Study (16). The latter study included
424 patients with overall bifurcation lesions (LMDBLs
in 41 patients) and reported lower rates of TLR (6.1%)
and MACE (16.7%) at 3-year follow-up after culotte
stenting, almost half of the rates in the present study
(14.0% and 23.7%). These differences in TLR and
MACE might be related to the discriminations in
baseline characteristics between the Nordic Stent
Study and the DKCRUSH-III study: less diabetes (15%
vs. 30.1%), no acute MI (0% vs. 5.1%), fewer LMDBLs
(9.6% vs. 100%), and more false bifurcation lesions
(18% vs. 0%). On the other hand, compared with
classic crush in the Nordic Stent Study (16), classic
crush stenting was associated lower rates of TLR
(3.8% vs. 6.2%) and MACE (8.2% vs. 20.6%) at 3 years
after the indexed procedures, which was even better
than those in a recent study using a T-stent technique
and sirolimus-eluting stent (TLR in 10%) (17), in line
with previous DKCRUSH-II (Double Kissing Crush
versus Provisional Stenting Technique for Treatment
of Coronary Bifurcation Lesions) study (18), which
only included true bifurcation lesions (Medina 1,1,1
and 0,1,1). Thus, DK crush seems to be a promising
technique for true and complex bifurcation lesions.
For bifurcation lesions, a complex stenting app-
roach has been an independent factor for ST
(19–21), although there are no convincing data after
stenting LMDBLs. Similar to the 1-year ST rate (<1%)
in the ISAR-LEFT MAIN (14) trial, the ST rate (1.0%)
after culotte stenting in the DKCRUSH-III study is
slightly lower than the 1.9% rate reported by Erglis
et al. (12) and the 1.6% rate reported by Adriaenssens
et al. (22). However, the long-term rate of ST was only
reported by the present study and the Nordic Stent
Study (16). We found that an overall rate of ST at
3-year follow-up was 3.9% after culotte stenting,
nearly one-half the rate (7.1%) reported in the Nordic
Stent Study (16). Less use of IVUS could not be
excluded from the explanation of the higher ST rate
after culotte stenting from that study. Previous
studies have demonstrated the reduced rates of MI,
cardiac death, and ST by IVUS-guided stenting pro-
cedure (23–25). Our previous study showed that even
if DK crush was used for bifurcation lesions, IVUS-
guided procedure could improve the procedural
quality (less malaposition, edge dissection, and stent
expansion) (25). Furthermore, Gao et al. (26) reported
a trend of a reduced 1-year ST rate if stenting left
main disease was guided by IVUS. Bench test reported
that a “napkin” or a gap or a metallic ridge (27) is
usually seen at the ostial SB after culotte stenting,
PERSPECTIVES
WHAT IS KNOWN? Stenting DLMBLs is technically challenging
and associated with unfavorable results. DK crush stenting, a
systematic 2-stent technique, was found in the previous study to
be superior to culotte stenting for left main bifurcations.
WHAT IS NEW? We report less frequent ST and revasculari-
zation by DK crush during 3-year follow-up.
WHAT IS NEXT? Further study is required to compare DK crush
stenting with provisional stenting for left main bifurcations.
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1341leading to the failure to fully cover the ostial SB and
resulting in increased in-stent restenosis, TLR, and ST.
Our another important ﬁnding was the absence of
deﬁnite and probable ST at 3-year follow-up after DK
crush stenting, suggesting the importance of stenting
techniques in improving the safety of stenting
LMDBLs. Obviously, 1 advantage of the DK crush
stenting technique is the introduction of ﬁrst kissing
inﬂation immediately after balloon crush, which may
improve the stent expansion (10,12). Furthermore,
alternative inﬂation using a noncompliant balloon
with a minimal of 16 atm followed by kissing balloon
inﬂation and proximal optimal technique during DK
crush stenting (12) is another critical point to maintain
a better stent apposition. Subsequently, less metal
overlap, fully expanded stent at the ostial SB, and less
distortion achieved by DK crush should be correlated
with improved 3-year clinical results. Based on the
strict criteria for recruitment of participating centers in
our study, the difference in 3-yearMACEwas less likely
related to the insufﬁcient experience for operators.
In general, LMDBLs haves intrinsic differences in
terms of anatomic features. Our previous DEFINITION
study (11) found that complex bifurcation lesions
were roughly seen in one-third of overall bifurcation
lesions, consistent with our current results (28%).
From our serial analysis, the 3-year rates of TLR
and MACE after stenting complex LMDBLs were
extremely higher than those after stenting simplex
LMDBLs, particularly after culotte stenting. Stenting
complex LMDBLs using DK crush still tends to be
associated with increased rates of TLR,TVR, MACE,
and ST, even though it did not achieve signiﬁcance
when compared with stenting simple LMDBLs using
the DK crush approach. Taking previous studies
(10,18) into consideration, we propose that LMDBLs
should be stratiﬁed according to DEFINITION criteria
(11) or scoring systems (2,3,19) before making de-
cisions about the revascularization approach and the
selection of stenting techniques.
STUDY LIMITATIONS. We did not include a CABG
group to contrast with the stenting techniques. How-
ever, the promising results achieved by the DK crushtechnique were comparable to those after CABG.
Another limitation is that angiographic follow-up was
scheduled for 8 months after indexed procedure,
which might increase the rate of revascularization.
CONCLUSIONS
This randomized, multicenter study suggests that,
compared with the DK crush technique, culotte
stenting is associated with signiﬁcantly increased
MACE in patients with LMDBLs, especially in patients
with complex lesions. Further studies are necessary
to compare DK crush with provisional T-stenting in
patients with complex LMDBLs.
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